Hillhouse, Quan Capital Lead $93M Series B Round In Biopharma Firm NextCure

This Data Is Locked!

This area is available only to Subscribers.

Chinese investment firms Hillhouse Capital and Quan Capital have invested US$93 million in a series B equity financing round in bio-pharmaceutical company NextCure Inc., which... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?